These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9453437)

  • 1. Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans.
    Milkiewicz P; Baiocchi L; Mills CO; Ahmed M; Khalaf H; Keogh A; Baker J; Elias E
    J Hepatol; 1997 Dec; 27(6):1106-9. PubMed ID: 9453437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma elimination of cholyl-lysyl-fluorescein (CLF): a pilot study in patients with liver cirrhosis.
    Milkiewicz P; Saksena S; Cardenas T; Mills CO; Elias E
    Liver; 2000 Jul; 20(4):330-4. PubMed ID: 10959812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: a study in isolated hepatocyte couplets and TR- rats.
    Mills CO; Milkiewicz P; Müller M; Roma MG; Havinga R; Coleman R; Kuipers F; Jansen PL; Elias E
    J Hepatol; 1999 Oct; 31(4):678-84. PubMed ID: 10551392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver.
    Mills CO; Rahman K; Coleman R; Elias E
    Biochim Biophys Acta; 1991 Dec; 1115(2):151-6. PubMed ID: 1764467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, physical and biological properties of lithocholyl-lysyl-fluorescein: a fluorescent monohydroxy bile salt analogue with cholestatic properties.
    Mills CO; Milkiewicz P; Molloy DP; Baxter DJ; Elias E
    Biochim Biophys Acta; 1997 Oct; 1336(3):485-96. PubMed ID: 9367176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic carboxypeptidase hydrolysis of bile acid-amino conjugates: selective resistance of glycine and taurine amidates.
    Huijghebaert SM; Hofmann AF
    Gastroenterology; 1986 Feb; 90(2):306-15. PubMed ID: 2867000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization.
    Holzinger F; Schteingart CD; Ton-Nu HT; Cerrè C; Steinbach JH; Yeh HZ; Hofmann AF
    Hepatology; 1998 Aug; 28(2):510-20. PubMed ID: 9696018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative biliary tree imaging with cholyl-lysyl-fluorescein: an experimental study in the rabbit.
    Oddi A; Mills CO; Custureri F; Di Nicola V; Elias E; Di Matteo G
    Surg Laparosc Endosc; 1996 Jun; 6(3):198-200. PubMed ID: 8743362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary lipid output by isolated perfused rat livers in response to cholyl-lysylfluorescein.
    Baxter DJ; Rahman K; Bushell AJ; Mills CO; Elias E; Billington D
    Biochim Biophys Acta; 1995 Jun; 1256(3):374-80. PubMed ID: 7786902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the amino acid moiety on deconjugation of bile acid amidates by cholylglycine hydrolase or human fecal cultures.
    Huijghebaert SM; Hofmann AF
    J Lipid Res; 1986 Jul; 27(7):742-52. PubMed ID: 2876046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. 3. Cholyltaurine (taurocholic acid).
    Hepner GW; Sturman JA; Hofmann AF; Thomas PJ
    J Clin Invest; 1973 Feb; 52(2):433-40. PubMed ID: 4683882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.
    de Waart DR; Häusler S; Vlaming ML; Kunne C; Hänggi E; Gruss HJ; Oude Elferink RP; Stieger B
    J Pharmacol Exp Ther; 2010 Jul; 334(1):78-86. PubMed ID: 20388726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of evidence for vesicle trafficking of fluorescent bile salts in rat hepatocyte couplets.
    El-Seaidy AZ; Mills CO; Elias E; Crawford JM
    Am J Physiol; 1997 Feb; 272(2 Pt 1):G298-309. PubMed ID: 9124354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease.
    Thjodleifsson B; Barnes S; Chitranukroh A; Billing BH; Sherlock S
    Gut; 1977 Sep; 18(9):697-702. PubMed ID: 23982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. I. Cholylglycine.
    Hepner GW; Hofmann AF; Thomas PJ
    J Clin Invest; 1972 Jul; 51(7):1889-97. PubMed ID: 5032529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition.
    Ryan J; Morgan RE; Chen Y; Volak LP; Dunn RT; Dunn KW
    Drug Metab Dispos; 2018 May; 46(5):704-718. PubMed ID: 29467212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholyllysyl fluroscein and related lysyl fluorescein conjugated bile acid analogues.
    Mills CO; Milkiewicz P; Saraswat V; Elias E
    Yale J Biol Med; 1997; 70(4):447-57. PubMed ID: 9626765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of hepatic bile acid conjugation in the rat.
    Suchy FJ; Courchene SM; Balistreri WF
    Pediatr Res; 1985 Jan; 19(1):97-101. PubMed ID: 2982127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary choloyl-PABA excretion in diagnosing small intestinal bacterial overgrowth: evaluation of a new noninvasive method.
    Bardhan PK; Feger A; Kogon M; Muller J; Gillessen D; Beglinger C; Gyr N
    Dig Dis Sci; 2000 Mar; 45(3):474-9. PubMed ID: 10749320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms.
    Burgon PG; Stanton PG; Robertson DM
    Endocrinology; 1996 Nov; 137(11):4827-36. PubMed ID: 8895353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.